Drug intelligence / Profile preview

Androvet

Development stage
Unknown
Lead developer
Laboratorios Q Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Androvet is an oral dietary supplement developed and marketed by the Spanish pharmaceutical company Laboratorios Q Pharma. It is specifically formulated to support male reproductive health and address male factor infertility associated with oxidative stress. The supplement contains a combination of three key antioxidant components: selenium, lycopene, and vitamin E. Selenium is an essential trace element that acts as a cofactor for glutathione peroxidase enzymes, which are critical for protecting sperm during maturation. Lycopene, a carotenoid, and vitamin E (tocopherol) serve as potent lipophilic antioxidants that scavenge reactive oxygen species, thereby protecting sperm cell membranes and DNA from oxidative damage. By reducing systemic and local oxidative stress, Androvet aims to improve sperm parameters such as motility, morphology, and concentration.

Brand names
Androvet
Other names
Selenium + Lycopene + Vitamin E
02

Targets

GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on Androvet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Androvet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call